Cargando…
Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron’s outbreak
Continuous appearance of SARS-CoV-2 variants and mass vaccination have been intricately influencing on the COVID-19 situation. To elucidate the current status in Japan, we analyzed totally 2,000 sera in August (n = 1,000) and December (n = 1,000) 2021 collected from individuals who underwent a healt...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982849/ https://www.ncbi.nlm.nih.gov/pubmed/35381036 http://dx.doi.org/10.1371/journal.pone.0266270 |
_version_ | 1784681871358033920 |
---|---|
author | Ren, Zhenxiao Nishimura, Mitsuhiro Tjan, Lidya Handayani Furukawa, Koichi Kurahashi, Yukiya Sutandhio, Silvia Aoki, Kaito Hasegawa, Natsumi Arii, Jun Uto, Kenichi Matsui, Keiji Sato, Itsuko Saegusa, Jun Godai, Nonoka Takeshita, Kohei Yamamoto, Masaki Nagashima, Tatsuya Mori, Yasuko |
author_facet | Ren, Zhenxiao Nishimura, Mitsuhiro Tjan, Lidya Handayani Furukawa, Koichi Kurahashi, Yukiya Sutandhio, Silvia Aoki, Kaito Hasegawa, Natsumi Arii, Jun Uto, Kenichi Matsui, Keiji Sato, Itsuko Saegusa, Jun Godai, Nonoka Takeshita, Kohei Yamamoto, Masaki Nagashima, Tatsuya Mori, Yasuko |
author_sort | Ren, Zhenxiao |
collection | PubMed |
description | Continuous appearance of SARS-CoV-2 variants and mass vaccination have been intricately influencing on the COVID-19 situation. To elucidate the current status in Japan, we analyzed totally 2,000 sera in August (n = 1,000) and December (n = 1,000) 2021 collected from individuals who underwent a health check-up. The anti-N seropositive rate were 2.1% and 3.9% in August and December 2021, respectively, demonstrating a Delta variant endemic during that time; it was approximately twofold higher than the rate based on the PCR-based diagnosis. The anti-S seropositive rate was 38.7% in August and it reached 90.8% in December, in concordance with the vaccination rate in Japan. In the December cohort, 78.7% of the sera showed neutralizing activity against the Delta variant, whereas that against the Omicron was much lower at 36.6%. These analyses revealed that effective immunity against the Delta variant was established in December 2021, however, prompt three-dose vaccination is needed to overcome Omicron’s outbreak. |
format | Online Article Text |
id | pubmed-8982849 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-89828492022-04-06 Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron’s outbreak Ren, Zhenxiao Nishimura, Mitsuhiro Tjan, Lidya Handayani Furukawa, Koichi Kurahashi, Yukiya Sutandhio, Silvia Aoki, Kaito Hasegawa, Natsumi Arii, Jun Uto, Kenichi Matsui, Keiji Sato, Itsuko Saegusa, Jun Godai, Nonoka Takeshita, Kohei Yamamoto, Masaki Nagashima, Tatsuya Mori, Yasuko PLoS One Research Article Continuous appearance of SARS-CoV-2 variants and mass vaccination have been intricately influencing on the COVID-19 situation. To elucidate the current status in Japan, we analyzed totally 2,000 sera in August (n = 1,000) and December (n = 1,000) 2021 collected from individuals who underwent a health check-up. The anti-N seropositive rate were 2.1% and 3.9% in August and December 2021, respectively, demonstrating a Delta variant endemic during that time; it was approximately twofold higher than the rate based on the PCR-based diagnosis. The anti-S seropositive rate was 38.7% in August and it reached 90.8% in December, in concordance with the vaccination rate in Japan. In the December cohort, 78.7% of the sera showed neutralizing activity against the Delta variant, whereas that against the Omicron was much lower at 36.6%. These analyses revealed that effective immunity against the Delta variant was established in December 2021, however, prompt three-dose vaccination is needed to overcome Omicron’s outbreak. Public Library of Science 2022-04-05 /pmc/articles/PMC8982849/ /pubmed/35381036 http://dx.doi.org/10.1371/journal.pone.0266270 Text en © 2022 Ren et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Ren, Zhenxiao Nishimura, Mitsuhiro Tjan, Lidya Handayani Furukawa, Koichi Kurahashi, Yukiya Sutandhio, Silvia Aoki, Kaito Hasegawa, Natsumi Arii, Jun Uto, Kenichi Matsui, Keiji Sato, Itsuko Saegusa, Jun Godai, Nonoka Takeshita, Kohei Yamamoto, Masaki Nagashima, Tatsuya Mori, Yasuko Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron’s outbreak |
title | Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron’s outbreak |
title_full | Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron’s outbreak |
title_fullStr | Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron’s outbreak |
title_full_unstemmed | Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron’s outbreak |
title_short | Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron’s outbreak |
title_sort | large-scale serosurveillance of covid-19 in japan: acquisition of neutralizing antibodies for delta but not for omicron and requirement of booster vaccination to overcome the omicron’s outbreak |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982849/ https://www.ncbi.nlm.nih.gov/pubmed/35381036 http://dx.doi.org/10.1371/journal.pone.0266270 |
work_keys_str_mv | AT renzhenxiao largescaleserosurveillanceofcovid19injapanacquisitionofneutralizingantibodiesfordeltabutnotforomicronandrequirementofboostervaccinationtoovercometheomicronsoutbreak AT nishimuramitsuhiro largescaleserosurveillanceofcovid19injapanacquisitionofneutralizingantibodiesfordeltabutnotforomicronandrequirementofboostervaccinationtoovercometheomicronsoutbreak AT tjanlidyahandayani largescaleserosurveillanceofcovid19injapanacquisitionofneutralizingantibodiesfordeltabutnotforomicronandrequirementofboostervaccinationtoovercometheomicronsoutbreak AT furukawakoichi largescaleserosurveillanceofcovid19injapanacquisitionofneutralizingantibodiesfordeltabutnotforomicronandrequirementofboostervaccinationtoovercometheomicronsoutbreak AT kurahashiyukiya largescaleserosurveillanceofcovid19injapanacquisitionofneutralizingantibodiesfordeltabutnotforomicronandrequirementofboostervaccinationtoovercometheomicronsoutbreak AT sutandhiosilvia largescaleserosurveillanceofcovid19injapanacquisitionofneutralizingantibodiesfordeltabutnotforomicronandrequirementofboostervaccinationtoovercometheomicronsoutbreak AT aokikaito largescaleserosurveillanceofcovid19injapanacquisitionofneutralizingantibodiesfordeltabutnotforomicronandrequirementofboostervaccinationtoovercometheomicronsoutbreak AT hasegawanatsumi largescaleserosurveillanceofcovid19injapanacquisitionofneutralizingantibodiesfordeltabutnotforomicronandrequirementofboostervaccinationtoovercometheomicronsoutbreak AT ariijun largescaleserosurveillanceofcovid19injapanacquisitionofneutralizingantibodiesfordeltabutnotforomicronandrequirementofboostervaccinationtoovercometheomicronsoutbreak AT utokenichi largescaleserosurveillanceofcovid19injapanacquisitionofneutralizingantibodiesfordeltabutnotforomicronandrequirementofboostervaccinationtoovercometheomicronsoutbreak AT matsuikeiji largescaleserosurveillanceofcovid19injapanacquisitionofneutralizingantibodiesfordeltabutnotforomicronandrequirementofboostervaccinationtoovercometheomicronsoutbreak AT satoitsuko largescaleserosurveillanceofcovid19injapanacquisitionofneutralizingantibodiesfordeltabutnotforomicronandrequirementofboostervaccinationtoovercometheomicronsoutbreak AT saegusajun largescaleserosurveillanceofcovid19injapanacquisitionofneutralizingantibodiesfordeltabutnotforomicronandrequirementofboostervaccinationtoovercometheomicronsoutbreak AT godainonoka largescaleserosurveillanceofcovid19injapanacquisitionofneutralizingantibodiesfordeltabutnotforomicronandrequirementofboostervaccinationtoovercometheomicronsoutbreak AT takeshitakohei largescaleserosurveillanceofcovid19injapanacquisitionofneutralizingantibodiesfordeltabutnotforomicronandrequirementofboostervaccinationtoovercometheomicronsoutbreak AT yamamotomasaki largescaleserosurveillanceofcovid19injapanacquisitionofneutralizingantibodiesfordeltabutnotforomicronandrequirementofboostervaccinationtoovercometheomicronsoutbreak AT nagashimatatsuya largescaleserosurveillanceofcovid19injapanacquisitionofneutralizingantibodiesfordeltabutnotforomicronandrequirementofboostervaccinationtoovercometheomicronsoutbreak AT moriyasuko largescaleserosurveillanceofcovid19injapanacquisitionofneutralizingantibodiesfordeltabutnotforomicronandrequirementofboostervaccinationtoovercometheomicronsoutbreak |